Navigate Fool.com
Will OPXA beat
the market?
Community Rating: 1 Star: Ominous

1.49 -0.02 (-1.32%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $1.51
Previous Close $1.51
Daily Range $1.46 - $1.57
52-Week Range $1.25 - $3.70
Market Cap $41.0M
P/E Ratio -1.19
Dividend (Yield) $0.00 (0.0%)
Volume 265,417
Average Daily Volume 729,970
Current FY EPS -$0.46

How do you think OPXA
will perform against the market?

Top OPXA Bull/Bear Pitches


pugnaciously (< 20)
Submitted November 14, 2011

Fast Track status just announced by the FDA for its multiple sclerosis drug, Tovaxin. It is currently in Stage IIb of clinical trials, thus far showing effectiveness where other drugs have failed. N … More

2 Replies Reply Report this Post

zzlangerhans (< 20)
Submitted November 8, 2011

I was actually thinking about green thumbing Opexa yesterday after I noticed they had fallen through the lower end of my value range, but I decided to revise the range downward instead. What I saw in … More

2 Replies Reply Report this Post

News & Commentary






A biopharmaceutical company developing autologous cellular therapies to treat several major illnesses, including multiple sclerosis, rheumatoid arthritis, diabetes, and cardiovascular disease. Website: http://www.opexatherapeutics.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks